Glen D. Park

1.4k total citations
27 papers, 1.1k citations indexed

About

Glen D. Park is a scholar working on Emergency Medicine, Pharmacology and Pharmacology. According to data from OpenAlex, Glen D. Park has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Emergency Medicine, 5 papers in Pharmacology and 5 papers in Pharmacology. Recurrent topics in Glen D. Park's work include Poisoning and overdose treatments (9 papers), Pharmacology and Obesity Treatment (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Glen D. Park is often cited by papers focused on Poisoning and overdose treatments (9 papers), Pharmacology and Obesity Treatment (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Glen D. Park collaborates with scholars based in United States. Glen D. Park's co-authors include Reynold Spector, Charles M. Clark, Sherwyn Schwartz, Julio Rosenstock, David W. Donley, George F. Johnson, Mark J. Goldberg, William G. Berlinger, Elliot S. Vesell and Ross D. Feldman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Diabetes Care.

In The Last Decade

Glen D. Park

27 papers receiving 977 citations

Peers

Glen D. Park

EDM

PHARM

SURGE

PHARM

Michel Andréjak France

Suman Wason United States

J. P. Kampmann Denmark

Ramanuj Achari United States

E Bercoff France

Laurie Blendis Canada

Charles E. Halstenson United States

P Greminger Switzerland

K. D. G. Edwards Australia

Loralie J. Langman United States

Michel Andréjak France

Glen D. Park

179 ×0.5

EDM

105 ×0.3

219 ×1.2

PHARM

396 ×2.3

SURGE

66 ×0.4

PHARM

Citations per year, relative to Glen D. Park Glen D. Park (= 1×) peers Michel Andréjak

Countries citing papers authored by Glen D. Park

Since Specialization

Citations

This map shows the geographic impact of Glen D. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glen D. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glen D. Park more than expected).

Fields of papers citing papers by Glen D. Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glen D. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glen D. Park. The network helps show where Glen D. Park may publish in the future.

Co-authorship network of co-authors of Glen D. Park

This figure shows the co-authorship network connecting the top 25 collaborators of Glen D. Park. A scholar is included among the top collaborators of Glen D. Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glen D. Park. Glen D. Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Glen D. & Jules T. Mitchel. (2016). Working with the U.S. Food and Drug Administration to obtain approval of products under the Animal Rule. Annals of the New York Academy of Sciences. 1374(1). 10–16. 15 indexed citations

Rosenstock, Julio, et al.. (2001). Basal Insulin Therapy in Type 2 Diabetes. Diabetes Care. 24(4). 631–636. 394 indexed citations

Meeves, Suzanne & Glen D. Park. (1994). The Use of Confidence Intervals to Describe the Precision of Trough/Peak Ratios for Diltiazem CD in the Treatment of Hypertension. The Journal of Clinical Pharmacology. 34(3). 231–235. 5 indexed citations

Felicetta, James V., Neal R. Cutler, Thomas J. Comstock, et al.. (1992). A dose-response trial of once-daily diltiazem. American Heart Journal. 123(4). 1022–1026. 26 indexed citations

Massie, Barry M., et al.. (1992). 24‐hour efficacy of once‐daily diltiazem in essential hypertension. Clinical Cardiology. 15(5). 365–368. 24 indexed citations

Kitt, Therese M., Glen D. Park, Reynold Spector, & Eva Tsalikian. (1989). Reduced Renal Clearance of Oxypurinol During a 400 Calorie Protein‐Free Diet. The Journal of Clinical Pharmacology. 29(1). 65–71. 3 indexed citations

Park, Glen D., Reynold Spector, & Therese M. Kitt. (1989). Effect of Dietary Protein on Renal Tubular Clearance of Drugs in Humans. Clinical Pharmacokinetics. 17(6). 441–451. 7 indexed citations

Park, Glen D., Reynold Spector, & Therese M. Kitt. (1988). Superactivated Charcoal Versus Cholestyramine for Cholesterol Lowering: A Randomized Cross‐Over Trial. The Journal of Clinical Pharmacology. 28(5). 416–419. 2 indexed citations

Spector, Reynold, Glen D. Park, George F. Johnson, & Elliot S. Vesell. (1988). Therapeutic drug monitoring. Clinical Pharmacology & Therapeutics. 43(4). 345–353. 80 indexed citations

10.

Kitt, Therese M., Glen D. Park, Reynold Spector, William J. Lawton, & Eva Tsalikian. (1988). Renal clearances of oxypurinol and inulin on an isocaloric, low-protein diet. Clinical Pharmacology & Therapeutics. 43(6). 681–687. 3 indexed citations

11.

Park, Glen D., Reynold Spector, Mark J. Goldberg, & Ross D. Feldman. (1987). Digoxin Toxicity in Patients with High Serum Digoxin Concentrations. The American Journal of the Medical Sciences. 294(6). 423–428. 9 indexed citations

12.

Park, Glen D., et al.. (1987). The effect of dietary protein-calorie restriction on the renal elimination of cimetidine. Clinical Pharmacology & Therapeutics. 42(4). 471–475. 2 indexed citations

13.

Park, Glen D., William G. Berlinger, Reynold Spector, Therese M. Kitt, & Eva Tsalikian. (1987). Sustained reductions in oxipurinol renal clearance during a restricted diet. Clinical Pharmacology & Therapeutics. 41(6). 616–621. 6 indexed citations

14.

Park, Glen D.. (1986). Expanded Role of Charcoal Therapy in the Poisoned and Overdosed Patient. Archives of Internal Medicine. 146(5). 969–969. 60 indexed citations

15.

Goldberg, Mark J., Glen D. Park, Reynold Spector, Lawrence J. Fischer, & Ross D. Feldman. (1985). Lack of effect of oral activated charcoal on imipramine clearance. Clinical Pharmacology & Therapeutics. 38(3). 350–353. 30 indexed citations

16.

Park, Glen D., Mark J. Goldberg, Reynold Spector, et al.. (1985). The Effects of Activated Charcoal on Digoxin and Digitoxin Clearance. Drug Intelligence & Clinical Pharmacy. 19(12). 937–941. 38 indexed citations

17.

Park, Glen D., et al.. (1984). Model for theophylline overdose treatment with oral activated charcoal. Clinical Pharmacology & Therapeutics. 35(3). 402–408. 53 indexed citations

18.

Park, Glen D., Reynold Spector, Robert J. Roberts, et al.. (1983). Use of hemoperfusion for treatment of theophylline intoxication. The American Journal of Medicine. 74(6). 961–966. 68 indexed citations

19.

Park, Glen D., et al.. (1983). Effects of size and frequency of oral doses of charcoal on theophylline clearance. Clinical Pharmacology & Therapeutics. 34(5). 663–666. 57 indexed citations

20.

Park, Glen D.. (1982). Serious Adverse Reactions Associated With Sulindac. Archives of Internal Medicine. 142(7). 1292–1292. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact